MB
IDYA icon

MPM BioImpact’s IDEAYA Biosciences IDYA Stock Holding History

MPM BioImpact’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-430,161
Closed -$7.05M – 46
2025
Q1 		$7.05M Buy
430,161
+16,126
+4% +$344K 1.21% 34
2024
Q4 		$10.6M Buy
+414,035
New +$11.7M 1.51% 32

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

MPM BioImpact's IDYA Position: Q2 2025 in Review

MPM BioImpact sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 430,161 shares — an estimated $7.05M sold.

MPM BioImpact first reported a position in IDYA in Q4 2024 and held it in 2 quarters. The position peaked at $10.6M in Q4 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

  • MPM BioImpact reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
  • MPM BioImpact sold 430,161 IDEAYA Biosciences shares in Q2 2025, an estimated $7.05M.
  • MPM BioImpact first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 2 quarters.
  • MPM BioImpact's IDEAYA Biosciences position peaked at $10.6M in Q4 2024.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on MPM BioImpact's 13F filing for Q2 2025, filed 14 Aug 2025.